Antitrust Antitrust

Pharmaceutical industry faces Australian cartel scrutiny

By Laurel Henning
  • 23 May 2022 07:34
  • 23 May 2022 07:34
Pharmaceutical companies are the subject of an ongoing cartel investigation by Australia’s antitrust regulator, MLex understands.

The Australian Competition & Consumer Commission, or ACCC, which has seen a recent change in senior leadership, is understood to have a number of investigations underway, of which the pharmaceutical-industry probe is one.

In an interview

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News